questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Chimiokines
Chimiokines CXC
Chimiokine CXCL1
Chimiokine CXCL1 : Questions médicales fréquentes
Diagnostic
5
Chimiokines
CXCL1
Tests de laboratoire
Inflammation
Protéines C-réactives
Vitesse de sédimentation
Biomarqueurs
Maladies inflammatoires
Cancer
Liquides biologiques
CXCL1
Plasma
Infections
Neutrophiles
Diagnostic
Symptômes
5
Symptômes
Inflammation
Douleur
Maladies respiratoires
Asthme
CXCL1
Réponse immunitaire
Chimiokines
Inflammation
Symptômes systémiques
Fièvre
Fatigue
Signes cliniques
Œdème
Rougeur
Prévention
5
Prévention
Infections
Allergènes
Alimentation
Antioxydants
Inflammation
Exercice physique
Inflammation
CXCL1
Stress
Inflammation
CXCL1
Vaccinations
Réponse immunitaire
CXCL1
Traitements
5
Traitements
Anticorps monoclonaux
Inhibiteurs de chimiokines
Anti-inflammatoires
AINS
Inflammation
Corticostéroïdes
CXCL1
Inflammation
Thérapies géniques
CXCL1
Recherche
Traitements biologiques
CXCL1
Inflammation
Complications
5
Complications
Maladies auto-immunes
Infections chroniques
Cicatrisation
Inflammation
CXCL1
Maladies respiratoires
BPCO
CXCL1
Risques cardiovasculaires
Inflammation
CXCL1
Facteurs de risque
5
Facteurs de risque
Infections
Obésité
Tabagisme
Inflammation
CXCL1
Maladies métaboliques
Diabète
CXCL1
Polluants
Environnement
CXCL1
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chimiokine CXCL1 : Questions médicales les plus fréquentes",
"headline": "Chimiokine CXCL1 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chimiokine CXCL1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-18",
"dateModified": "2026-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL1"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Chimiokines CXC",
"url": "https://questionsmedicales.fr/mesh/D019743",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokines CXC",
"code": {
"@type": "MedicalCode",
"code": "D019743",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.120"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CXCL1",
"alternateName": "Chemokine CXCL1",
"code": {
"@type": "MedicalCode",
"code": "D054360",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Krishna Rajarathnam",
"url": "https://questionsmedicales.fr/author/Krishna%20Rajarathnam",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, United States."
}
},
{
"@type": "Person",
"name": "Noha Mousaad Elemam",
"url": "https://questionsmedicales.fr/author/Noha%20Mousaad%20Elemam",
"affiliation": {
"@type": "Organization",
"name": "College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates."
}
},
{
"@type": "Person",
"name": "Azzam A Maghazachi",
"url": "https://questionsmedicales.fr/author/Azzam%20A%20Maghazachi",
"affiliation": {
"@type": "Organization",
"name": "College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates."
}
},
{
"@type": "Person",
"name": "J Robert Lane",
"url": "https://questionsmedicales.fr/author/J%20Robert%20Lane",
"affiliation": {
"@type": "Organization",
"name": "Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom."
}
},
{
"@type": "Person",
"name": "Meritxell Canals",
"url": "https://questionsmedicales.fr/author/Meritxell%20Canals",
"affiliation": {
"@type": "Organization",
"name": "Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37408240",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells12101406"
}
},
{
"@type": "ScholarlyArticle",
"name": "Structural insights into KSHV-GPCR constitutive activation and CXCL1 chemokine recognition.",
"datePublished": "2024-10-08",
"url": "https://questionsmedicales.fr/article/39378089",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1073/pnas.2403217121"
}
},
{
"@type": "ScholarlyArticle",
"name": "The role of CXCL1/CXCR2 axis in neurological diseases.",
"datePublished": "2023-05-27",
"url": "https://questionsmedicales.fr/article/37247498",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.intimp.2023.110330"
}
},
{
"@type": "ScholarlyArticle",
"name": "TGFβ1 induces CXCL1 to promote stemness features in lung cancer.",
"datePublished": "2023-12-30",
"url": "https://questionsmedicales.fr/article/38158808",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/15353702231220662"
}
},
{
"@type": "ScholarlyArticle",
"name": "CXCL1 promotes immune escape in colorectal cancer by autophagy-mediated MHC-I degradation.",
"datePublished": "2023-10-04",
"url": "https://questionsmedicales.fr/article/37802708",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.humimm.2023.09.002"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chimiokines",
"item": "https://questionsmedicales.fr/mesh/D018925"
},
{
"@type": "ListItem",
"position": 6,
"name": "Chimiokines CXC",
"item": "https://questionsmedicales.fr/mesh/D019743"
},
{
"@type": "ListItem",
"position": 7,
"name": "Chimiokine CXCL1",
"item": "https://questionsmedicales.fr/mesh/D054360"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chimiokine CXCL1 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chimiokine CXCL1",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chimiokine CXCL1",
"description": "Comment mesurer les niveaux de CXCL1 ?\nQuels tests sont utilisés pour évaluer l'inflammation ?\nCXCL1 est-il un biomarqueur de maladies ?\nPeut-on détecter CXCL1 dans les liquides biologiques ?\nQuel rôle joue CXCL1 dans le diagnostic des infections ?",
"url": "https://questionsmedicales.fr/mesh/D054360#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chimiokine CXCL1",
"description": "Quels symptômes sont liés à une élévation de CXCL1 ?\nCXCL1 est-il associé à des maladies respiratoires ?\nComment CXCL1 affecte-t-il la réponse immunitaire ?\nCXCL1 peut-il provoquer des symptômes systémiques ?\nQuels signes cliniques indiquent une activation de CXCL1 ?",
"url": "https://questionsmedicales.fr/mesh/D054360#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chimiokine CXCL1",
"description": "Comment prévenir l'activation de CXCL1 ?\nUne alimentation saine aide-t-elle à réguler CXCL1 ?\nL'exercice physique influence-t-il CXCL1 ?\nLe stress affecte-t-il CXCL1 ?\nLes vaccinations influencent-elles CXCL1 ?",
"url": "https://questionsmedicales.fr/mesh/D054360#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chimiokine CXCL1",
"description": "Quels traitements ciblent CXCL1 ?\nComment réduire l'inflammation liée à CXCL1 ?\nLes corticostéroïdes affectent-ils CXCL1 ?\nY a-t-il des thérapies géniques pour CXCL1 ?\nLes traitements biologiques influencent-ils CXCL1 ?",
"url": "https://questionsmedicales.fr/mesh/D054360#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chimiokine CXCL1",
"description": "Quelles complications sont liées à une élévation de CXCL1 ?\nCXCL1 est-il impliqué dans le cancer ?\nComment CXCL1 affecte-t-il la cicatrisation ?\nCXCL1 peut-il aggraver des maladies respiratoires ?\nY a-t-il des risques cardiovasculaires liés à CXCL1 ?",
"url": "https://questionsmedicales.fr/mesh/D054360#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chimiokine CXCL1",
"description": "Quels facteurs augmentent les niveaux de CXCL1 ?\nL'âge influence-t-il les niveaux de CXCL1 ?\nLe tabagisme affecte-t-il CXCL1 ?\nLes maladies métaboliques influencent-elles CXCL1 ?\nL'exposition à des polluants affecte-t-elle CXCL1 ?",
"url": "https://questionsmedicales.fr/mesh/D054360#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer les niveaux de CXCL1 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de CXCL1 peuvent être mesurés par des tests ELISA dans le sérum ou les tissus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'inflammation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la CRP et la vitesse de sédimentation peuvent être utilisés en complément."
}
},
{
"@type": "Question",
"name": "CXCL1 est-il un biomarqueur de maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, CXCL1 est associé à des maladies inflammatoires et certains cancers."
}
},
{
"@type": "Question",
"name": "Peut-on détecter CXCL1 dans les liquides biologiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, CXCL1 peut être détecté dans le plasma, le liquide synovial et d'autres fluides."
}
},
{
"@type": "Question",
"name": "Quel rôle joue CXCL1 dans le diagnostic des infections ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "CXCL1 aide à identifier l'inflammation et l'infection en attirant les neutrophiles."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une élévation de CXCL1 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, rougeur et gonflement au site d'inflammation."
}
},
{
"@type": "Question",
"name": "CXCL1 est-il associé à des maladies respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de CXCL1 sont observés dans des maladies comme l'asthme."
}
},
{
"@type": "Question",
"name": "Comment CXCL1 affecte-t-il la réponse immunitaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "CXCL1 attire les cellules immunitaires, augmentant ainsi la réponse inflammatoire."
}
},
{
"@type": "Question",
"name": "CXCL1 peut-il provoquer des symptômes systémiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une élévation de CXCL1 peut entraîner des symptômes comme la fièvre et la fatigue."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une activation de CXCL1 ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur et œdème au site d'inflammation sont des signes cliniques."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'activation de CXCL1 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les facteurs déclenchants comme les infections et l'exposition aux allergènes."
}
},
{
"@type": "Question",
"name": "Une alimentation saine aide-t-elle à réguler CXCL1 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut aider à moduler l'inflammation."
}
},
{
"@type": "Question",
"name": "L'exercice physique influence-t-il CXCL1 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier peut réduire l'inflammation et les niveaux de CXCL1."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il CXCL1 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter les niveaux de CXCL1 et l'inflammation."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles CXCL1 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations peuvent moduler la réponse immunitaire et les niveaux de CXCL1."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent CXCL1 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de chimiokines et des anticorps monoclonaux peuvent cibler CXCL1."
}
},
{
"@type": "Question",
"name": "Comment réduire l'inflammation liée à CXCL1 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anti-inflammatoires non stéroïdiens (AINS) peuvent aider à réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes affectent-ils CXCL1 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire l'expression de CXCL1 et l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies géniques pour CXCL1 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur les thérapies géniques pour moduler CXCL1."
}
},
{
"@type": "Question",
"name": "Les traitements biologiques influencent-ils CXCL1 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements biologiques peuvent réduire les niveaux de CXCL1."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à une élévation de CXCL1 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des maladies auto-immunes et des infections chroniques peuvent survenir."
}
},
{
"@type": "Question",
"name": "CXCL1 est-il impliqué dans le cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, CXCL1 est associé à la progression tumorale et à la métastase dans certains cancers."
}
},
{
"@type": "Question",
"name": "Comment CXCL1 affecte-t-il la cicatrisation ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une élévation de CXCL1 peut retarder la cicatrisation en maintenant l'inflammation."
}
},
{
"@type": "Question",
"name": "CXCL1 peut-il aggraver des maladies respiratoires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de CXCL1 peuvent aggraver des maladies comme la BPCO."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques cardiovasculaires liés à CXCL1 ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'inflammation chronique associée à CXCL1 peut augmenter le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent les niveaux de CXCL1 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections, le stress, et l'obésité sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les niveaux de CXCL1 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de CXCL1 peuvent augmenter avec l'âge en raison de l'inflammation chronique."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il CXCL1 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter les niveaux de CXCL1 et l'inflammation pulmonaire."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques influencent-elles CXCL1 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète peuvent augmenter les niveaux de CXCL1."
}
},
{
"@type": "Question",
"name": "L'exposition à des polluants affecte-t-elle CXCL1 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des polluants environnementaux peut augmenter les niveaux de CXCL1."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/04/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, United States.
Institute for Human Infections and Immunity, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, United States.
Sealy Center for Structural Biology and Molecular Biophysics, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, United States.
Publications dans "Chimiokine CXCL1" :
3 publications dans cette catégorie
Affiliations :
College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Publications dans "Chimiokine CXCL1" :
3 publications dans cette catégorie
Affiliations :
College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Publications dans "Chimiokine CXCL1" :
3 publications dans cette catégorie
Affiliations :
Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, United Kingdom.
Publications dans "Chimiokine CXCL1" :
3 publications dans cette catégorie
Affiliations :
Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Nottingham, United Kingdom.
Publications dans "Chimiokine CXCL1" :
3 publications dans cette catégorie
Affiliations :
Monash Biomedicine Discovery Institute, and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
Department of Anatomy and Histology, Collegium Medicum, University of Zielona Góra, Zyty 28 St., 65-046 Zielona Góra, Poland.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
Department of Functional Diagnostics and Physical Medicine, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, Żołnierska 54 Str., 71-210 Szczecin, Poland.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72, 70-111 Szczecin, Poland.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, United States.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, United States.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, United States.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, United States.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, United States.
Institute for Human Infections and Immunity, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, United States.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology and Stroke, Medical University of Lodz, 90-549 Lodz, Poland.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Urology and Institutes for Systems Genetics, West China Hospital, Sichuan University, Chengdu 610041, China.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Urology and Institutes for Systems Genetics, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: bairong.shen@scu.edu.cn.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin, Berlin, Germany.
Publications dans "Chimiokine CXCL1" :
2 publications dans cette catégorie
Affiliations :
Department of Transfusion Medicine, Charité-Universitätsmedizin, Berlin, Germany.
Publications dans "Chimiokine CXCL1" :
One area of cancer research is the interaction between cancer cells and immune cells, in which chemokines play a vital role. Despite this, a comprehensive summary of the involvement of C-X-C motif lig...
Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a viral G protein-coupled receptor, KSHV-GPCR, that contributes to KSHV immune evasion and pathogenesis of Kaposi's sarcoma. KSHV-GPCR shares a h...
The C-X-C chemokine ligand (CXCL) 1 and its receptor C-X-C chemokine receptor (CXCR) 2 are widely expressed in the peripheral nervous systems (PNS) and central nervous systems (CNS) and are involved i...
Chemokines critically orchestrate the tumorigenesis, metastasis, and stemness features of cancer cells that lead to poor outcomes. High plasma levels of transforming growth factor-β1 (TGFβ1) correlate...
Immunotherapy is now seen as a potential remedy for colorectal cancer (CRC). Chemokines play a crucial role in tumors, including CRC, which contains CXCL1. We attempted to study how CXCL1 impacts immu...
Bioinformatics analysis was used to examine CXCL1 level in CRC. qRT-PCR was used to assess CXCL1 and MHC-I (HLA-A, B, C) levels. Cell Counting Kit-8 (CCK-8) was used to measure cell viability. Cytotox...
Bioinformatics analysis and qRT-PCR presented that CXCL1 was upregulated in CRC. Cell experiments demonstrated that CXCL1 overexpression promoted immune escape in CRC. Rescue experiments revealed that...
CXCL1 promoted immune escape in CRC by autophagy-mediated MHC-I degradation, suggesting that CXCL1 may be a possible immunotherapeutic target for CRC....
Esophageal squamous-cell carcinoma (ESCC) is commonly treated with radiotherapy; however, radioresistance hinders its clinical effectiveness, and the underlying mechanism remains elusive. Here, we dev...
Rheumatoid arthritis (RA) is the most common autoimmune disease, affecting the joints of the hands and feet. Several chemokines and their receptors are crucial in RA pathogenesis through immune cell r...
Emerging studies have identified chronic psychological stress as an independent risk factor influencing breast cancer growth and metastasis. However, the effects of chronic psychological stress on pre...
The effects and molecular mechanisms of chronic unpredictable mild stress (CUMS) on modulating tumor-associated macrophages (TAMs) and PMN formation were clarified by multiplex immunofluorescence tech...
CUMS significantly promoted breast cancer growth and metastasis, accompanied by TAMs accumulation in the microenvironment. CXCL1 was identified as a crucial chemokine in TAMs facilitating PMN formatio...
Our findings shed new light on the association between chronic psychological stress and splenic MDSC mobilization, and suggest that stress-related glucocorticoid elevation can enhance TAM/CXCL1 signal...
Astrocytes play an important role in the regulation of the inflammatory response in the CNS, e.g., in demyelinating diseases. Since the chemokine CXCL1 is known to be secreted by astrocytes and to hav...
A high expression pattern of minichromosome maintenance 2 (MCM2) has been observed in various cancers. MCM2 is a protein involved in the cell cycle and plays a role in cancer growth and differentiatio...
MCM2 has shown high expression in both lung cancer stem cells (LCSCs) and glioma stem cells (GSCs). We investigated the characteristics of CSCs and the regulation of the epithelial-to-mesenchymal tran...
There was a significant difference in survival rates between lung cancer patients and brain cancer patients based on MCM2 expression. MCM2 was found to regulate both markers and regulatory proteins in...
MCM2 not only participates in the cell cycle but also affects cancer cell growth by regulating the external microenvironment to create a favorable environment for cells. MCM2 is highly expressed in ma...